CA2024381A1 - Composes de xanthine - Google Patents

Composes de xanthine

Info

Publication number
CA2024381A1
CA2024381A1 CA2024381A CA2024381A CA2024381A1 CA 2024381 A1 CA2024381 A1 CA 2024381A1 CA 2024381 A CA2024381 A CA 2024381A CA 2024381 A CA2024381 A CA 2024381A CA 2024381 A1 CA2024381 A1 CA 2024381A1
Authority
CA
Canada
Prior art keywords
effect
renal
lower alkyl
diuretic
independently represents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2024381A
Other languages
English (en)
Other versions
CA2024381C (fr
Inventor
Fumio Suzuki
Junichi Shimada
Akio Ishii
Tetsuji Ohno
Akira Karasawa
Kazuhiro Kubo
Hiromi Nonaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of CA2024381A1 publication Critical patent/CA2024381A1/fr
Application granted granted Critical
Publication of CA2024381C publication Critical patent/CA2024381C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/20—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/22—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one sulfur atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
CA002024381A 1989-09-01 1990-08-31 Composes de xanthine Expired - Fee Related CA2024381C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP226642/89 1989-09-01
JP22664289 1989-09-01

Publications (2)

Publication Number Publication Date
CA2024381A1 true CA2024381A1 (fr) 1991-03-02
CA2024381C CA2024381C (fr) 1997-01-07

Family

ID=16848383

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002024381A Expired - Fee Related CA2024381C (fr) 1989-09-01 1990-08-31 Composes de xanthine

Country Status (11)

Country Link
EP (1) EP0415456B1 (fr)
JP (1) JPH06102662B2 (fr)
AT (1) ATE139778T1 (fr)
BR (1) BR1100762A (fr)
CA (1) CA2024381C (fr)
CY (1) CY2069B1 (fr)
DE (1) DE69027562T2 (fr)
DK (1) DK0415456T3 (fr)
ES (1) ES2091212T3 (fr)
GR (1) GR3020715T3 (fr)
HK (1) HK1000600A1 (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3843117A1 (de) * 1988-12-22 1990-06-28 Boehringer Ingelheim Kg Neue xanthinderivate mit adenosin-antagonistischer wirkung
US5290782A (en) * 1989-09-01 1994-03-01 Kyowa Hakko Kogyo Co., Ltd. Xanthine derivatives
DE4019892A1 (de) * 1990-06-22 1992-01-02 Boehringer Ingelheim Kg Neue xanthinderivate
CA2061544A1 (fr) * 1991-02-25 1992-08-26 Fumio Suzuki Composes de la xanthine
EP0541120B1 (fr) * 1991-11-08 1999-05-26 Kyowa Hakko Kogyo Co., Ltd. Dérivés de Xanthine pour le traitement de la démence
EP0556778A3 (en) * 1992-02-17 1993-11-24 Kyowa Hakko Kogyo Kk Xanthine derivatives
US5342841A (en) * 1992-03-12 1994-08-30 Kyowa Hakko Kogyo Co., Ltd. Xanthine derivatives
US5484920A (en) * 1992-04-08 1996-01-16 Kyowa Hakko Kogyo Co., Ltd. Therapeutic agent for Parkinson's disease
TW252044B (fr) * 1992-08-10 1995-07-21 Boehringer Ingelheim Kg
JP2613355B2 (ja) * 1992-09-28 1997-05-28 協和醗酵工業株式会社 パーキンソン氏病治療剤
DE4238367A1 (de) * 1992-11-13 1994-05-19 Boehringer Ingelheim Kg Diuretisches Mittel
WO1994016702A1 (fr) * 1993-01-26 1994-08-04 Kyowa Hakko Kogyo Co., Ltd. Medicament contre l'elimination irreguliere des matieres fecales
US5395836A (en) * 1993-04-07 1995-03-07 Kyowa Hakko Kogyo Co., Ltd. 8-tricycloalkyl xanthine derivatives
US5736528A (en) * 1993-10-28 1998-04-07 University Of Florida Research Foundation, Inc. N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists
US5446046A (en) * 1993-10-28 1995-08-29 University Of Florida Research Foundation A1 adenosine receptor agonists and antagonists as diuretics
EP0711772A4 (fr) * 1994-05-17 1996-12-04 Kyowa Hakko Kogyo Kk Procede pour produire un derive de xanthine
EP0799040B1 (fr) 1994-12-13 2003-08-20 Euroceltique S.A. Thioxanthines trisubstituees
US6025361A (en) * 1994-12-13 2000-02-15 Euro-Celtique, S.A. Trisubstituted thioxanthines
WO1996018399A1 (fr) * 1994-12-13 1996-06-20 Euro-Celtique, S.A. Aryle thioxanthines
ATE240734T1 (de) * 1995-07-26 2003-06-15 Kyowa Hakko Kogyo Kk Zubereitung von xanthinderivaten als feste dispersion
US5864037A (en) * 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
US5789416B1 (en) * 1996-08-27 1999-10-05 Cv Therapeutics Inc N6 mono heterocyclic substituted adenosine derivatives
AU7675498A (en) * 1997-06-16 1999-01-04 Kyowa Hakko Kogyo Co. Ltd. Preventive and remedy for drug-induced nephropathy
DE19816857A1 (de) * 1998-04-16 1999-10-21 Boehringer Ingelheim Pharma Neue unsymmetrisch substituierte Xanthin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP0970696A1 (fr) * 1998-05-05 2000-01-12 Kyowa Hakko Kogyo Co., Ltd. Composition comprenant des diurétiques d'anse et des antagonists des recepteurs A1 de l'adenosine
WO1999062553A1 (fr) * 1998-06-01 1999-12-09 Fujisawa Pharmaceutical Co., Ltd. Medicaments contre la sterilite masculine
US6576619B2 (en) 1999-05-24 2003-06-10 Cv Therapeutics, Inc. Orally active A1 adenosine receptor agonists
NZ519427A (en) 1999-11-12 2003-08-29 Biogen Inc Polycycloalkylpurine derivative useful as an adenosine receptor antagonist
PL206890B1 (pl) * 1999-11-12 2010-10-29 Biogen Idec Ma Pochodna bicykloalkilopuryny, jej zastosowanie i kompozycja leku
MXPA02010552A (es) 2000-04-26 2003-03-10 Eisai Co Ltd Composicion farmaceutica que promueve la defecacion.
GEP20094697B (en) 2000-12-01 2009-06-10 Biogen Idec Inc Condensed purine derivatives as a1 adenosine receptor antagonists
TWI301834B (en) 2001-10-22 2008-10-11 Eisai R&D Man Co Ltd Pyrimidone compound and pharmaceutical composition including the same
MXPA04012629A (es) * 2002-06-12 2005-10-18 Biogen Idec Inc Metodo para el tratamiento de lesion de reperfusion por isquemia por medio de antagonistas receptores de adenosina.
US20040229901A1 (en) * 2003-02-24 2004-11-18 Lauren Otsuki Method of treatment of disease using an adenosine A1 receptor antagonist
ATE403656T1 (de) * 2003-05-06 2008-08-15 Cv Therapeutics Inc Xanthinderivate als a2b- adenosinrezeptorantagonisten
RU2357969C2 (ru) * 2003-08-25 2009-06-10 АДЕНОЗАЙН ТЕРАПЬЮТИКС, ЭлЭлСи Новые замещенные 8-гетероарилксантины и фармацевтическая композиция на их основе
US20100168140A1 (en) 2005-12-14 2010-07-01 Kyowa Hakko Kogyo Co., Ltd. Easily Absorbable Oral Preparations of Xanthine Derivatives
GB0708258D0 (en) * 2007-04-27 2007-06-06 Katholleke Universiteit Leuven New anti-viral nulceoside analogs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1245969B (de) * 1967-08-03 VEB Arzneimittelwerk Dresden, Radebeul Verfahren zur Herstellung von Xanthinderivaten
GB1201997A (en) * 1967-08-04 1970-08-12 Yissum Res Dev Co New substituted purines and purine derivatives
GB8618931D0 (en) * 1986-08-02 1986-09-10 Euro Celtique Sa 6-thioxanthines
US4783530A (en) * 1986-11-13 1988-11-08 Marion Laboratories, Inc. 8-arylxanthines
DE3843117A1 (de) * 1988-12-22 1990-06-28 Boehringer Ingelheim Kg Neue xanthinderivate mit adenosin-antagonistischer wirkung

Also Published As

Publication number Publication date
JPH03173889A (ja) 1991-07-29
HK1000600A1 (en) 1998-04-09
JPH06102662B2 (ja) 1994-12-14
CA2024381C (fr) 1997-01-07
DE69027562D1 (de) 1996-08-01
BR1100762A (pt) 2000-03-14
ES2091212T3 (es) 1996-11-01
DE69027562T2 (de) 1997-02-20
EP0415456B1 (fr) 1996-06-26
CY2069B1 (en) 1998-09-11
ATE139778T1 (de) 1996-07-15
DK0415456T3 (da) 1996-07-29
EP0415456A3 (en) 1991-05-29
GR3020715T3 (en) 1996-11-30
EP0415456A2 (fr) 1991-03-06

Similar Documents

Publication Publication Date Title
CA2024381A1 (fr) Composes de xanthine
CA2067929A1 (fr) Derives de piperazine
EP0236935A3 (fr) Purine-nucléosides carboxyliques, leur production et utilisation
CA2028235A1 (fr) Derives puriques condenses
CA2001203A1 (fr) Dithiocarbamoyl quinolones antimicrobiens
CA2116387A1 (fr) Derives d'oxazolidinedione, leur production et leur utilisation
CA2094859A1 (fr) Sulfites et sulfates cycliques de fructopyranose a action anticonvulsive
CA2040517A1 (fr) Derives de 1,8-naphtyridin-2-one
CA2040086A1 (fr) Nouveau 4h-pyrido[1,2-a]pyrimidin-4-ones 2,9-disubstituees
CA2002834A1 (fr) Xanthines cycloalkyles
RU93056600A (ru) Фенокси- и феноксиалкилпиперидиновые соединения и антивирусная композиция
EP0031567A3 (fr) Dérivés de tétrapeptidesemicarbazide, leur production et leur utilisation
EP0375668A3 (fr) Phényléthylamines, procédé de leur préparation et composition les contenant
EP0128007A3 (fr) Dérivés phényliques de l'acide tétrahydronaphtylcarboxylique
IE851734L (en) Isoindolinyl-alkyl-piperazines
CA2158130A1 (fr) Methode et produits intermediaires pour la preparation d'azabicyclo(2.2.2)octan-3-imines
CA2199568A1 (fr) Derives de vinylcyclopropane multifonctionnels
KR910014380A (ko) 이미자조피리다진 화합물, 그의 제법 및 용도
EP0245990A3 (fr) Composés antihypercholestérolémiques
ES2003086A6 (es) Procedimiento de obtencion de tienoquinolicinsulfonamidas
AU615589B2 (en) Benzothiadiazepine derivatives
EP0147181A3 (fr) Dérivés de l'acide thiazolylacétique et leur préparation
SE8705196D0 (sv) Pyrimidinderivat
EP0245004A3 (fr) Composés antihypercholestérolémiques
EP0103357A3 (fr) Composés de phénylpipérazine substitués, appropriés comme agents antihypertensifs, et les procédés de leur préparation

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed